Vision and mission


Oasmia’s vision is to improve and facilitate treatments of serious diseases by developing new treatment options to manage cancer diseases. Oasmia also aims to contribute to a larger number of people being cured of cancer and to increase the quality of life for both humans and animals through access to new effective drugs.


Oasmia’s mission is to utilise the Company’s proprietary technology platform XR17 in order to develop intravenous drugs with enhanced solubility for APIs that add value to patients and stakeholders.